rs2646164

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000079.4(CHRNA1):​c.235-385C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 1 in 1,613,942 control chromosomes in the GnomAD database, including 806,214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 1.0 ( 75802 hom., cov: 32)
Exomes 𝑓: 1.0 ( 730412 hom. )

Consequence

CHRNA1
NM_000079.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.00800

Publications

6 publications found
Variant links:
Genes affected
CHRNA1 (HGNC:1955): (cholinergic receptor nicotinic alpha 1 subunit) The muscle acetylcholine receptor consiststs of 5 subunits of 4 different types: 2 alpha subunits and 1 each of the beta, gamma, and delta subunits. This gene encodes an alpha subunit that plays a role in acetlycholine binding/channel gating. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Nov 2012]
CHRNA1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 1A
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • myasthenic syndrome, congenital, 1B, fast-channel
    Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-174758060-G-A is Benign according to our data. Variant chr2-174758060-G-A is described in ClinVar as Benign. ClinVar VariationId is 257237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNA1NM_000079.4 linkc.235-385C>T intron_variant Intron 3 of 8 ENST00000348749.9 NP_000070.1 P02708-2Q53SH4
CHRNA1NM_001039523.3 linkc.235-40C>T intron_variant Intron 3 of 9 NP_001034612.1 P02708-1Q53SH4
CHRNA1XM_017003256.2 linkc.256-40C>T intron_variant Intron 2 of 8 XP_016858745.1
CHRNA1XM_017003257.2 linkc.256-385C>T intron_variant Intron 2 of 7 XP_016858746.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNA1ENST00000348749.9 linkc.235-385C>T intron_variant Intron 3 of 8 1 NM_000079.4 ENSP00000261008.5 P02708-2

Frequencies

GnomAD3 genomes
AF:
0.998
AC:
151855
AN:
152226
Hom.:
75743
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.992
Gnomad AMI
AF:
0.997
Gnomad AMR
AF:
0.999
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
1.00
GnomAD2 exomes
AF:
0.999
AC:
248515
AN:
248648
AF XY:
1.00
show subpopulations
Gnomad AFR exome
AF:
0.993
Gnomad AMR exome
AF:
1.00
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
1.00
GnomAD4 exome
AF:
1.00
AC:
1461206
AN:
1461598
Hom.:
730412
Cov.:
41
AF XY:
1.00
AC XY:
726939
AN XY:
727112
show subpopulations
African (AFR)
AF:
0.990
AC:
33137
AN:
33470
American (AMR)
AF:
1.00
AC:
44692
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26132
AN:
26132
East Asian (EAS)
AF:
1.00
AC:
39698
AN:
39698
South Asian (SAS)
AF:
1.00
AC:
86240
AN:
86242
European-Finnish (FIN)
AF:
1.00
AC:
53404
AN:
53404
Middle Eastern (MID)
AF:
1.00
AC:
5768
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111780
AN:
1111788
Other (OTH)
AF:
0.999
AC:
60355
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21666
43332
64998
86664
108330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.998
AC:
151973
AN:
152344
Hom.:
75802
Cov.:
32
AF XY:
0.998
AC XY:
74324
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.992
AC:
41229
AN:
41570
American (AMR)
AF:
0.999
AC:
15289
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5182
AN:
5182
South Asian (SAS)
AF:
1.00
AC:
4825
AN:
4826
European-Finnish (FIN)
AF:
1.00
AC:
10620
AN:
10620
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68037
AN:
68044
Other (OTH)
AF:
1.00
AC:
2116
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.999
Hom.:
13177
Bravo
AF:
0.997
Asia WGS
AF:
1.00
AC:
3477
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myasthenic syndrome, congenital, 1B, fast-channel Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lethal multiple pterygium syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 1A Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.9
DANN
Benign
0.87
PhyloP100
0.0080
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2646164; hg19: chr2-175622788; API